Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Mattucci-Cerinic

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Frontiers in Cardiovascular Medicine|August 12, 2022
Editorial: Cardiovascular involvement in autoimmune diseasesSophie I Mavrogeni, Lambros Fotis, Paraskevi V Voulgari, et al.
The Journal of Rheumatology|December 7, 2005
Scleroderma--developing measures of responseDaniel E Furst, Dinesh Khanna, Marco Mattucci-Cerinic, et al.
Journal of Clinical Medicine|July 27, 2022
Effectiveness of Golimumab as Second Anti-TNFα Drug in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis in Italy: GO-BEYOND, a Prospective Real-World Observational StudySalvatore D'Angelo, Enrico Tirri, Angela Maria Giardino, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Frontiers in Cardiovascular Medicine|August 12, 2022
Editorial: Cardiovascular involvement in autoimmune diseasesSophie I Mavrogeni, Lambros Fotis, Paraskevi V Voulgari, et al.
The Journal of Rheumatology|December 7, 2005
Scleroderma--developing measures of responseDaniel E Furst, Dinesh Khanna, Marco Mattucci-Cerinic, et al.
Journal of Clinical Medicine|July 27, 2022
Effectiveness of Golimumab as Second Anti-TNFα Drug in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis in Italy: GO-BEYOND, a Prospective Real-World Observational StudySalvatore D'Angelo, Enrico Tirri, Angela Maria Giardino, et al.
Pageof 1